Back
KLBF - Kalbe Farma

KLBF – No significant impact from Trump’s policy

14 August 2025

KLBF – No significant impact from Trump’s policy Kalbe Farma (KLBF) has not experienced any significant impact from global trade tensions caused by Trump’s tariff policy on certain export products. Currently, KLBF has no sales exposure to the US, focusing instead on markets in ASEAN, Africa, and Asia. Note that, KLBF posted revenue of IDR17.07 tn (+4.5% yoy) and net profit of IDR2.02 tn (+10.77% yoy) in 1H25. For this year, KLBF targets revenue and net profit growth of around 6–8% yoy. (Source : Kontan)

Related Research

Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 May 2022 See Detail
Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 August 2025 See Detail
Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 June 2025 See Detail